The latest medical news on Ovarian Cancer

The research magnet gathers the latest research from around the web, based on your specialty area. Below you will find a sample of some of the most recent articles from reputable medical journals about ovarian cancer gathered by our medical AI research bot.

The selection below is filtered by medical specialty. Registered users get access to the Plexa Intelligent Filtering System that personalises your dashboard to display only content that is relevant to you.

Want more personalised results?

Request Access
Ovarian Cancer Research Alliance

Save the Date

Clearity Foundation for Ovarian Cancer

by Josh Friedman Key takeaways: AI-analyzed fragmentomes and protein biomarkers better distinguished women with ovarian cancer in screening. Liquid...

Ovarian Cancer Research Alliance

OCRA’s Advocate Leader committees recently gathered to strategize and mobilize for impactful change. Each committee aims to make strides in specifi...

Clearity Foundation for Ovarian Cancer

By Heidi Splete Many women with cancer want advice for managing sexual function issues, and clinicians are tuning in, new studies suggest. Decrease...

Clearity Foundation for Ovarian Cancer

Clearity’s Perspective: This article highlights the importance of learning ways to cope with and manage stress after an ovarian cancer diagnosis. T...

Clearity Foundation for Ovarian Cancer

by Charles Bankhead The FDA granted tumor-agnostic accelerated approval to trastuzumab deruxtecan (Enhertu) for previously treated unresectable or ...

Ovarian Cancer Research Alliance

This new, free tool is designed to connect patients with qualified healthcare professionals specializing in ovarian and gynecologic cancer care acr...

Ovarian Cancer Research Alliance

Frieda is founder of Hope for Heather, an OCRA Community Partner; and is an OCRA Advocate Leader. Hope for Heather has donated over $700,000 to OCRA.

Clearity Foundation for Ovarian Cancer

Clearity’s Perspective: At the SGO meeting several presentations described how circulating tumor DNA (ctDNA) may be a new, personalized, sensitive ...

Clearity Foundation for Ovarian Cancer

By Ryan Scott Patients who are heavily pretreated with recurrent low-grade serous ovarian cancer (LGSOC) had high response rates, regardless of the...

Clearity Foundation for Ovarian Cancer

By Kristi Rosa Rezatapopt (PC14586) elicited responses with a favorable toxicity profile in heavily pretreated patients with advanced ovarian cance...

Ovarian Cancer Research Alliance

Learn why Tiffany Mecham, OCRA Advocate Leader, is using her platform as a contestant in the upcoming Mrs. Idaho pageant to raise awareness of ovar...